Product Information
OFLOXACIN 0.3% EAR DROPS is a generic product labeled by Leading Pharma, LLC, priced at $0.9789 per ML under NDC 69315032010. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Jan 5, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315032010
Classification
Generic
Dosage Form
SOLUTION
Route
AURICULAR (OTIC)
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA217903FDA Approved
1/5/2024
TE Code
AT
On Market Since
3/1/2024
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EAR DROPS has been published 122 times since Jun 5, 2024, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9789 per ML |
|---|---|
| All-time high | $1.7205 (Oct 16, 2024) |
| All-time low | $0.9468 (May 20, 2026) |
| 52-week high | $1.2312 |
| 52-week low | $0.9468 |
| Median price | $1.1956 |
| Average price | $1.2251 |
| Largest weekly change | +61.9% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OFLOXACIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EAR DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EAR DROPS, manufactured by Leading Pharma, LLC, is $0.9789 per ML (NDC 69315032010), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EAR DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EAR DROPS has declined 16.4%. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EAR DROPS?
Since Jun 5, 2024, the NADAC for OFLOXACIN 0.3% EAR DROPS has ranged from a low of $0.9468 (May 20, 2026) to a high of $1.7205 (Oct 16, 2024), with a median of $1.1956 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EAR DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OFLOXACIN 0.3% EAR DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures OFLOXACIN 0.3% EAR DROPS?
OFLOXACIN 0.3% EAR DROPS (NDC 69315032010) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.